Feedback Form
   
Add to Google
Promiscuous Antibody Targets Cancer
Sunday, March 22, 2009 - Sarah Gingichashvili
Home >> Headlines >> Cancer Research
  Peralink
Researchers have challenged an old immunological dogma — that an antibody can bind to only a single target or antigen — by engineering an antibody to bind tightly to two distinct proteins. The antibody, described in Science, blocks two proteins: vascular endothelial growth factor (VEGF) and human epidermal growth factor receptor 2 (HER2). VEGF is thought to promote growth in tumours, and HER2 is highly expressed by some aggressive breast tumours.    (source: nature.com)


Related News Innate Immunity to Cancer Innate Immunity to Cancer Cancer Vaccination in Action Cancer Vaccination in Action

Related Pictures Purple Tomatoes to Fight Cancer Purple Tomatoes to Fight Cancer New Contrast Agent to Help Fight Cancer New Contrast Agent to Help Fight Cancer

Other Articles Smart-Bombing Cancer Smart-Bombing Cancer The Future of Electronic Paper The Future of Electronic Paper

No comments have been posted for this item.

Add a New Comment
Your name:   0/20
Subject:  0/30
Your Comment:  0/999
Type the following letters: Visual CAPTCHA
Please keep your comments related to the above item's topic. TFOT reserves the right to delete any unrelated comment without notice.

Picture Of The Day
Floating Jelly Hat
Floating Jelly Hat

Video
Paralysed Rats Sprint
Paralysed Rats Sprint

Site Of The Week
Galaxy Zoo
Galaxy Zoo

Personal Column
Detroit’s Dream of Aircraft Production
Dr. Daniel Uziel
Detroit’s Dream of Aircraft Production
Terms Of Use | Privacy Policy | Contact Us | Advertise With Us | Site Profile
Copyright © 2007 The Future of Things. All rights reserved.